Innosuisse Grant for Olivier Braissant & Bottmedical


Bottmedical, Universitäres Zentrum für Zahnmedizin Basel (UZB), University of Zurich and FHNW, secured a grant of more than 500.000 CHF for the development of orthodontic devices with natural antimicrobial substances effective against Streptococcus mutans, Streptococcus mitis and other oral pathogens.

Such properties, provided by cellulose‐based material loaded with essential oils such as cinnamaldehyde will help avoid caries during aligner treatment, but also to prevent gingivitis and periodontitis. Braissant will do the in vitro antimicrobial susceptibility testing of said materials and the reloading solutions against bacteria. Bottmedical will be providing their novel aligner technology.